...
首页> 外文期刊>Biochimica et Biophysica Acta. Gene Regulatory Mechanisms >Transcriptional regulation of Translocator protein (18 kDa) (TSPO) in microglia requires Pu.1, Ap1 and Sp factors
【24h】

Transcriptional regulation of Translocator protein (18 kDa) (TSPO) in microglia requires Pu.1, Ap1 and Sp factors

机译:微胶质细胞中易燃器蛋白(18kDa)(Tspo)的转录调节需要PU.1,AP1和SP因子

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mitochondrial Translocator protein (18 kDa) (TSPO) is strongly expressed in reactive microglia and serves as a therapeutic target for alleviation of neuronal degeneration. However, little is known about TSPO's transcriptional regulation in microglia. The aim of this study was to identify genetic elements and transcription factors required for basal and inducible TSPO expression in microglia. Murine Tspo promoter was cloned into the pGL4.10 luciferase vector and functionally characterized in BV-2 cells. Deletion mutagenesis indicated that 845 bases upstream were sufficient to reconstitute near maximal promoter activity in BV-2. Deletion of 593 to 520 sequences, which harbour an Apl, Ets.2 and Nkx3.1 site which also serves as a non-canonical binding site for Spl-family transcription factors, led to a dramatic decrease in both basal and LPS induced promoter activity. Further deletion of 168 to 39 sequences, which contains four GC boxes, also led to a significant decrease in promoter activity. Targeted mutations of Apl, Ets.2, Nkx3.1/Spl/3/4 and the GC boxes led to significant decreases in promoter activity. ChIP-qPCR revealed that Pu.1, Apl, Stat3, Spl, Sp3 and Sp4 bind to the endogenous Tspo promoter. Notably, binding of these factors, with the exception of Stat3, was significantly enhanced upon LPS treatment. RNAi silencing of Pu.1, cJun, cFos, Spl, Sp3, Sp4 and Stat3 strongly lowered Tspo promoter activity while Apl silencing inhibited LPS induced increase in Tspo protein levels. These findings demonstrate that consensus binding sequences for Apl, Ets.2, distal as well as proximal Sp1/3/4 sites regulate basal and LPS induced Tspo promoter activity in microglia.
机译:线粒体转移蛋白(18kDa)(Tspo)在反应性微胶质细胞中强烈表达,用作减轻神经元变性的治疗靶标。然而,关于TSPO在微胶质细胞中的转录调节很少。本研究的目的是鉴定基础和诱导微胶质细胞表达所需的遗传要素和转录因子。将鼠TSPO启动子克隆到PGL4.10荧光素酶向量中,并且在BV-2细胞中功能表征。缺失诱变表明上游845个碱基足以在BV-2中重组近最大启动子活性。缺失593至520个序列,其涉及APL,ETS.2和NKX3.1位点,该序列也用作SPL家族转录因子的非规范结合位点,导致基础和LPS诱导的启动子活性的显着降低。进一步缺失168至39个序列,其含有四个GC盒,也导致启动子活性的显着降低。 APL,ETS.2,NKX3.1 / SPL / 3/4和GC盒的靶向突变导致启动子活性的显着降低。 CHIP-QPCR显示PU.1,APL,STAT3,SPL,SP3和SP4与内源TSPO启动子结合。值得注意的是,在LPS治疗后明显增强了这些因素的结合,除了STAT3。 RNAI沉默PU.1,CJUN,CFOS,SPL,SP3,SP4和Stat3强烈降低了TSPO启动子活动,而APL沉默抑制LPS诱导的TSPO蛋白水平增加。这些发现表明,APL,ETE.2,远端以及近端SP1 / 3/4位点的共有凝聚序列调节基础和LPS在微胶质细胞中诱导的TSPO启动子活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号